No photo of Cristina Saura Manich

View Scopus Profile

Cristina Saura Manich

 https://orcid.org/0000-0001-8296-5065
    Calculated based on number of publications stored in Pure and citations from Scopus
    20202022

    Research activity per year

    Filter
    Article

    Search results

    • 2022

      Author Correction : High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer

      Palafox, M., Monserrat, L., Bellet Ezquerra, M., Villacampa Javierre, G., Gonzalez-Perez, A., Oliveira, M., Brasó-Maristany, F., Ibrahimi, N., Kannan, S., Mina, L., Herrera-Abreu, M. T., Òdena, A., Sánchez-Guixé, M., Capelán, M., Azaro, A., Bruna, A., Rodríguez, O., Guzmán, M., Grueso, J. & Viaplana, C. & 18 others, Hernandez-Losa, J., Su, F., Lin, K., Clarke, R. B., Caldas, C., Arribas, J. V., Michiels, S., García-Sanz, A., Turner, N. C., Prat, A., Nuciforo, P., Dienstmann, R., Verma, C. S., Lopez-Bigas, N., Scaltriti, M., Arnedos, M., Saura Manich, C. & Serra, V., 2022, In: Nature Communications. 13

      Research output: Contribution to journal › Article › Research › peer-review

      Open Access

    • GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells

      Bellio, C., Emperador, M., Castellano-Escuder, P., Gris-Oliver, A., Canals, F., Sánchez, A., Zamora, E., Arribas, J. V., Saura Manich, C., Serra, V., Littlefield, B. A. & Villanueva, J., 2022, In: Cancers. 14

      Research output: Contribution to journal › Article › Research › peer-review

      Open Access
      10 Citations (Scopus)

    • High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer

      Palafox, M., Monserrat, L., Bellet Ezquerra, M., Villacampa Javierre, G., Gonzalez-Perez, A., Oliveira, M., Brasó-Maristany, F., Ibrahimi, N., Kannan, S., Mina, L., Herrera-Abreu, M. T., Òdena, A., Sánchez-Guixé, M., Capelán, M., Azaro, A., Bruna, A., Rodríguez, O., Guzmán, M., Grueso, J. & Viaplana, C. & 18 others, Hernandez-Losa, J., Su, F., Lin, K., Clarke, R. B., Caldas, C., Arribas, J. V., Michiels, S., García-Sanz, A., Turner, N. C., Prat, A., Nuciforo, P., Dienstmann, R., Verma, C. S., Lopez-Bigas, N., Scaltriti, M., Arnedos, M., Saura Manich, C. & Serra, V., 2022, In: Nature Communications. 13

      Research output: Contribution to journal › Article › Research › peer-review

      Open Access
      50 Citations (Scopus)

    • Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance

      Serra, V., Wang, A. T., Castroviejo-Bermejo, M., Polanska, U., Palafox, M., Herencia Ropero, A., Jones, G., Lai, Z., Armenia, J., Michopoulos, F., Llop-Guevara, A., Brough, R., Gulati, A., Pettitt, S., Bulusu, K. C., Nikkila, J., Wilson, Z., Hughes, A., Wijnhoven, P. W. G. & Ahmed, A. & 20 others, Bruna, A., Gris-Oliver, A., Guzmán, M., Rodríguez, O., Grueso, J., Arribas, J. V., Cortés, J., Saura Manich, C., Lau, A., Critchlow, S., Dougherty, B., Caldas, C., Mills, G., Barrett, J. C., Forment, J. V., Cadogan, E., Lord, C. J., Cruz Zambrano, C., Balmaña Gelpí, J. & O'Connor, M. J., 2022, In: Clinical Cancer Research. 28, 20, p. 4536-4550 15 p.

      Research output: Contribution to journal › Article › Research › peer-review

      Open Access
      30 Citations (Scopus)

    • Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer

      Duro-Sánchez, S., Nadal-Serrano, M., Lalinde-Gutiérrez, M., Arenas, E. J., Bernadó Morales, C., Morancho, B., Escorihuela, M., Pérez-Ramos, S., Escrivá-de-Romaní, S., Gandullo-Sánchez, L., Pandiella, A., Esteve-Codina, A., Rodilla, V., Dijcks, F. A., Dokter, W. .. H. A., Cortés, J., Saura Manich, C. & Arribas, J. V., 2022, In: Journal of Cancer Research. 82, 24, p. 4670-4679 10 p.

      Research output: Contribution to journal › Article › Research › peer-review

      Open Access
      23 Citations (Scopus)
    • 2021

      Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy

      Saura Manich, C., Martínez, S., Domínguez Luengo, C., Dienstmann, R., Ruíz-Pace, F., Céspedes, M. C., Peñuelas, Á., Cortés, J., Llurba, E. & Córdoba, O., 2021, In: Cancers. 13

      Research output: Contribution to journal › Article › Research › peer-review

      Open Access
      1 Citation (Scopus)
    • 2020

      Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

      Garrido-Castro, A., Saura Manich, C., Barroso-Sousa, R., Guo, H., Ciruelos, E., Bermejo, B., Gavilá, J., Serra, V., Prat, A., Paré Brunet, L., Céliz, P., Villagrasa, P., Li, Y., Savoie, J., Xu, Z., Arteaga, C. L., Krop, I. E., Solit, D. B., Mills, G. & Cantley, L. C. & 3 others, Winer, E. P., Lin, N. U. & Rodon, J., 2020, In: Breast Cancer Research. 22

      Research output: Contribution to journal › Article › Research › peer-review

      Open Access
      79 Citations (Scopus)
    Your message has successfully been sent.
    Your message was not sent due to an error.